Dermal injection of immunocytes induces psoriasis.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Establishing direct and causal relationships among the confederacy of activated cell types present in psoriasis has been hampered by lack of an animal model.Within psoriatic plaques there are hyperplastic keratinocytes, infiltrating immunocytes, and activated endothelial cells.The purpose of this study was to determine if psoriasis is primarily a disorder of keratinocytes or the immune system.Using a newly developed experimental system in which full-thickness human skin is orthotopically transferred onto severe combined immunodeficient mice, autologous immunocytes were injected into dermis, and the resultant phenotype characterized by clinical, histologic, and immunophenotypic analyses.Engraftment of samples included both uninvolved/ symptomless (PN) skin removed from patients with psoriasis elsewhere, or from healthy individuals with no skin disease (NN skin).In 10 different experiments involving 6 different psoriasis patients, every PN skin was converted to a full-fledged psoriatic plaque skin by injection of autologous blood-derived immunocytes.In all but one psoriatic patient, the immunocytes required preactivation with IL-2 and superantigens to convert PN skin into psoriatic plaque skin.In every case, resultant plaques were characterized by visible presence of flaking and thickened skin, loss of the granular cell layer, prominent elongation of rete pegs with a dermal angiogenic tissue reaction, and infiltration within the epidermis by T cells.Lesional skin displayed 20 different antigenic determinants of the psoriatic phenotype.None of the four NN skin samples injected with autologous immunocytes converted to psoriatic plaques.We conclude that psoriasis is caused primarily by the ability of pathogenetic blood-derived immunocytes to induce secondary activation and disordered growth of endogenous cutaneous cells including keratinocytes and vascular endothelium.( J. Clin.Invest.1996.98:1878-1887.)Key words: psoriasis • T cells • severe combined immunodeficient mice • superantigen • antigen-presenting cell MethodsPatients.PN skin was biopsied (6 ϫ 2 ϫ 0.05 cm keratome containing both dermis and epidermis) from psoriatic patients ( n ϭ 6) after informed consent was obtained and the study approved by the University of Michigan Human Subjects Committee (Ann Arbor, MI).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Staphylococcal Enterotoxins and Their Relatives
Marrack, P., & Kappler, J. (1990) · Science · doi:10.1126/science.2185544 · Cited by 1,895
Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris
Henseler, T., & Christophers, E. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70188-0 · Cited by 1,005
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
The Natural History of Psoriasis in 5,600 Patients
Farber, E. M., & Nall, L. (1974) · Dermatology · doi:10.1159/000251595 · Cited by 599
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Schlaak, J. F., Buslau, M., Jochum, W., Hermann, E., Girndt, M., Gallati, H., Büschenfelde, K.-H. M. Z., & Fleischer, B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371752 · Cited by 455
Gene for Familial Psoriasis Susceptibility Mapped to the Distal End of Human Chromosome 17q
Tomfohrde, J., Silverman, A., Barnes, R., Fernandez-Vina, M. A., Young, M., Lory, D., Morris, L., Wuepper, K. D., Stastny, P., Menter, A., et al. (1994) · Science · doi:10.1126/science.8178173 · Cited by 426
Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?
Valdimarsson, H., Baker, B. S., Jónsdóttir, I., Powles, A., & Fry, L. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80132-4 · Cited by 358
Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin
CERIO, R., GRIFFITHS, C. E. M., COOPER, K. D., NICKOLOFF, B. J., & HEADINGTON, J. T. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb15509.x · Cited by 346
Self-citationThe Cytokine Network in Psoriasis
Nickoloff, B. J. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.6.871 · Cited by 344
Self-citationPsoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes
Valdimarsson, H., Bake, B. S., Jónsdótdr, I., & Fry, L. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90005-8 · Cited by 328
Cited by
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Immune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752
Self-citationThe immunologic basis for the treatment of psoriasis with new biologic agents
Krueger, J. G. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120568 · Cited by 600
Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 570
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Müller, A., deWaal Malefyt, R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6621 · Cited by 537
Boyman, O., Hefti, H. P., Conrad, C., Nickoloff, B. J., Suter, M., & Nestle, F. O. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031482 · Cited by 522
Self-citationAntimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Getting under the skin: the immunogenetics of psoriasis
Bowcock, A. M., & Krueger, J. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1689 · Cited by 484
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544
“use of animal models in which human skin was engrafted onto SCID mice (78, 79).”
MethodSelf-citationPathogenesis of psoriasis and development of treatment
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14139 · Cited by 456
Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H. D., & Döcke, W. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1476 · Cited by 415
Schafer, P., Parton, A., Gandhi, A., Capone, L., Adams, M., Wu, L., Bartlett, J., Loveland, M., Gilhar, A., Cheung, Y., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00559.x · Cited by 406
Immunopathogenic mechanisms in psoriasis
GUDJONSSON, J. E., JOHNSTON, A., SIGMUNDSDOTTIR, H., & VALDIMARSSON, H. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02310.x · Cited by 397
New insights of T cells in the pathogenesis of psoriasis
Cai, Y., Fleming, C., & Yan, J. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.15 · Cited by 389
Immunopathogenesis of psoriasis
Sabat, R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H., Sterry, W., & Wolk, K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00629.x · Cited by 373
TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques
Gottlieb, A. B., Chamian, F., Masud, S., Cardinale, I., Abello, M. V., Lowes, M. A., Chen, F., Magliocco, M., & Krueger, J. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2721 · Cited by 372
Diagnosis and classification of psoriasis
Raychaudhuri, S. K., Maverakis, E., & Raychaudhuri, S. P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.008 · Cited by 370
Abrams, J. R., Kelley, S. L., Hayes, E., Kikuchi, T., Brown, M. J., Kang, S., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Linsley, P. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.681 · Cited by 318
Conrad, C., Di Domizio, J., Mylonas, A., Belkhodja, C., Demaria, O., Navarini, A. A., Lapointe, A.-K., French, L. E., Vernez, M., & Gilliet, M. (2018) · Nature Communications · doi:10.1038/s41467-017-02466-4 · Cited by 317
The chemokine receptor D6 limits the inflammatory response in vivo
Jamieson, T., Cook, D. N., Nibbs, R. J. B., Rot, A., Nixon, C., Mclean, P., Alcami, A., Lira, S. A., Wiekowski, M., & Graham, G. J. (2005) · Nature Immunology · doi:10.1038/ni1182 · Cited by 302
Psoriatic arthritis: A unified concept twenty years on
McGonagle, D., Conaghan, P. G., & Emery, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1080::aid-anr2>3.0.co;2-7 · Cited by 301
Ozawa, M., Ferenczi, K., Kikuchi, T., Cardinale, I., Austin, L. M., Coven, T. R., Burack, L. H., & Krueger, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.711 · Cited by 298
Lew, W., Bowcock, A. M., & Krueger, J. G. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.006 · Cited by 284
The pathogenesis of psoriasis: immunological facts and speculations
Bos, J. D., & De Rie, M. A. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01381-4 · Cited by 284
The genetics of psoriasis: a complex disorder of the skin and immune system
Bhalerao, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.10.1537 · Cited by 274
Gudjonsson, J. E., Johnston, A., Dyson, M., Valdimarsson, H., & Elder, J. T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700807 · Cited by 266
Injection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis
Nickoloff, B. J., & Wrone-Smith, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65109-7 · Cited by 260
Self-citationGilhar, A., Ullmann, Y., Berkutzki, T., Assy, B., & Kalish, R. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci551 · Cited by 255
The pathogenic role of tissue-resident immune cells in psoriasis
Boyman, O., Conrad, C., Tonel, G., Gilliet, M., & Nestle, F. O. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.12.005 · Cited by 151
Sozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.897333 · Cited by 22
Florian, P., Flechsenhar, K. R., Bartnik, E., Ding‐Pfennigdorff, D., Herrmann, M., Bryce, P. J., & Nestle, F. O. (2020) · Experimental Dermatology · doi:10.1111/exd.13942 · Cited by 20
Metadata
- Authors
- Wrone-Smith, T., & Nickoloff, B. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-10-15
- Volume
- 98
- Issue
- 8
- Pages
- 1878-1887
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2090306216
- Cited by
- 439
- References
- 33
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.